No Data
No Data
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Cuts Target Price to $9
H.C. Wainwright analyst Robert Burns maintains $Caribou Biosciences(CRBU.US)$ with a buy rating, and adjusts the target price from $24 to $9.According to TipRanks data, the analyst has a success rate
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
During the last three months, 5 analysts shared their evaluations of Caribou Biosciences (NASDAQ:CRBU), revealing diverse outlooks from bullish to bearish.The table below provides a concise overview o
A Quick Look at Today's Ratings for Caribou Biosciences(CRBU.US), With a Forecast Between $3 to $17
On Jun 04, major Wall Street analysts update their ratings for $Caribou Biosciences(CRBU.US)$, with price targets ranging from $3 to $17.BofA Securities analyst Geoff Meacham maintains with a buy rati
Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Latest 28% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
If you want to know who really controls Caribou Biosciences, Inc. (NASDAQ:CRBU), then you'll have to look at the makeup of its share registry.
Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.
Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.
Caribou Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/04/2024 322.54% HC Wainwright & Co. $24 → $9 Maintains Buy 05/16/2024 792.02% Truist Securities $19 → $
No Data